What is Vizamyl, and what is it used for?
Vizamyl is a brand of florbetaben F 18 used in a positron emission tomography (PET) scan to help assess amyloid-β (Aβ) brain plaque. It is used in the context of evaluating suspected Alzheimer’s disease, because higher amyloid plaque burden can support the presence of Alzheimer’s-type pathology. [1]
How does Vizamyl work during a PET scan?
Florbetaben F 18 is a radioactive tracer that binds to amyloid-β plaques in the brain. During the PET scan, imaging signal reflects the presence of amyloid plaque, producing results that can be interpreted as supportive of amyloid pathology. [1]
Who is Vizamyl for?
Vizamyl is used for patients undergoing PET imaging in clinical settings where amyloid-β information is part of the diagnostic workup for Alzheimer’s disease. [1]
What do results from a Vizamyl PET scan mean?
Vizamyl PET is intended to indicate whether amyloid-β plaque is present at levels consistent with Alzheimer’s-type pathology. Interpretation depends on the imaging readout and clinical context. [1]
What are the common risks or side effects?
Like other PET radiotracers, the main considerations include radiation exposure from the tracer. Specific side effects and risk details depend on the prescribing information. [1]
Where can I find official prescribing information?
Official details (including indications, dosing for PET imaging, warnings, and side effects) are provided in the product’s U.S. prescribing information. [1]
Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203819